David Tweedie Selected Research

David Tweedie Research Topics

Disease

25	Neuroinflammatory Diseases 01/2024 - 09/2007
19	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024 - 09/2011
17	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2006
16	Inflammation (Inflammations) 03/2023 - 09/2007
12	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 09/2007
10	Parkinson Disease (Parkinson's Disease) 03/2024 - 01/2009
9	Nervous System Diseases (Neurological Disorders) 03/2023 - 07/2012
9	Stroke (Strokes) 04/2022 - 01/2009
8	Cognitive Dysfunction 11/2022 - 07/2012
8	Brain Concussion (Cerebral Concussion) 01/2020 - 10/2013
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2009
4	Multiple Myeloma 01/2024 - 01/2019
4	Ischemic Stroke 01/2023 - 05/2013
3	Gliosis 01/2024 - 03/2015
3	Neoplasms (Cancer) 01/2023 - 01/2017
3	Amyloid Plaque 01/2021 - 09/2006
2	Brain Injuries (Brain Injury) 03/2023 - 01/2019
2	Psoriatic Arthritis 09/2022 - 01/2019
2	Craniocerebral Trauma (Head Injury) 01/2020 - 09/2007
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2019 - 07/2012
2	Disease Progression 01/2019 - 05/2012
2	Blast Injuries 01/2016 - 02/2014
2	Infarction (Infarctions) 05/2013 - 03/2007
2	Memory Disorders (Memory Loss) 01/2013 - 09/2012
2	Neuroblastoma 06/2010 - 09/2006
1	Erythema Nodosum 01/2023
1	Leprosy (Hansen's Disease) 01/2023
1	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Post-Concussion Syndrome 01/2020
1	Brain Contusion 01/2020
1	Obesity 01/2020
1	Dyskinesias (Dyskinesia) 12/2019
1	Contusions 01/2019

Drug/Important Bio-Agent (IBA)

14	Thalidomide (Thalomid)FDA Link 03/2023 - 09/2007
13	CytokinesIBA 01/2024 - 10/2009
12	pomalidomideIBA 01/2024 - 01/2016
11	Proteins (Proteins, Gene)FDA Link 04/2021 - 09/2006
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 09/2007
9	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 06/2010
9	3,6'-dithiothalidomideIBA 12/2019 - 09/2011
9	Exenatide (Byetta)FDA Link 11/2019 - 01/2012
7	Glucagon-Like Peptide-1 ReceptorIBA 01/2016 - 01/2009
6	Immunomodulating AgentsIBA 01/2023 - 01/2019
6	Neuroprotective AgentsIBA 01/2022 - 12/2015
5	IncretinsIBA 03/2024 - 06/2010
4	Amyloid (Amyloid Fibrils)IBA 11/2022 - 01/2021
4	Cholinergic Agents (Cholinergics)IBA 02/2022 - 05/2008
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016 - 01/2007
3	LipopolysaccharidesIBA 03/2023 - 01/2011
3	Lenalidomide (CC 5013)FDA Link 01/2023 - 11/2015
3	ImidesIBA 01/2023 - 04/2022
3	SynucleinsIBA 04/2022 - 01/2020
3	Peptides (Polypeptides)IBA 02/2022 - 09/2006
3	ChemokinesIBA 01/2022 - 01/2020
3	phenserineIBA 01/2020 - 01/2016
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2019 - 02/2014
3	Amyloid beta-PeptidesIBA 01/2010 - 09/2006
2	alpha-SynucleinIBA 01/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2009
2	pifithrinIBA 01/2020 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	tartaric acid (tartrate)FDA Link 01/2020 - 10/2019
2	Glucagon (Glukagon)FDA Link 01/2020 - 04/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 10/2018
2	AntioxidantsIBA 10/2018 - 11/2015
2	Explosive Agents (Explosives)IBA 02/2014 - 06/2013
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2024
1	ras ProteinsIBA 11/2023
1	Protein Kinases (Protein Kinase)IBA 11/2023
1	ElementsIBA 01/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2022
1	Transcription Factors (Transcription Factor)IBA 09/2022
1	phthalimidineIBA 04/2021
1	KATP ChannelsIBA 01/2021
1	Presenilin-1IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Complement Inactivating AgentsIBA 01/2020
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2020
1	SomanIBA 01/2020
1	Nerve AgentsIBA 01/2020
1	fluoro-jade CIBA 01/2020
1	Annexin A5IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019
1	BenserazideIBA 12/2019
1	Levodopa (L Dopa)FDA LinkGeneric 12/2019
1	VimentinIBA 12/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2019
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 04/2019
1	fluoro jadeIBA 01/2019

Therapy/Procedure

6	Therapeutics 04/2022 - 09/2007
1	Oral Administration 03/2024